PALISADE BIO, INC. — Investor Relations & Filings
Filings indexed
1,045
across all filing types
Latest filing
2026-05-12
Regulatory Filings
Country
US
United States of America
Listing
US
PALI
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company that develops and advances novel therapeutics for patients with autoimmune, inflammatory, and fibrotic diseases. The company focuses on next-generation precision therapies, utilizing its phosphodiesterase-4 (PDE4) inhibitor prodrug platform. This platform is engineered to enable the targeted, oral delivery of therapeutics specifically to the gastrointestinal tract, aiming to enhance efficacy at the disease site while minimizing systemic side effects. Its lead development candidate, PALI-2108, is an oral PDE4 inhibitor prodrug being investigated for the treatment of inflammatory bowel diseases like ulcerative colitis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| S-3 - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | |
| 10-Q - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | |
| ARS - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-29 | English | |
| 8-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-02 | English | |
| 10-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-03-20 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
14 filings
| |||||
| 45341987 | S-3 - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | ||
| 45339305 | 10-Q - PALISADE BIO, INC. (0001357459) (Filer) | 2026-05-12 | English | ||
| 38828586 | ARS - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-29 | English | ||
| 33156249 | 8-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-04-02 | English | ||
| 33002255 | 10-K - PALISADE BIO, INC. (0001357459) (Filer) | 2026-03-20 | English | ||
| 29064240 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 29064235 | 4 Filing | 2026-02-13 | English | ||
| 29064230 | SCHEDULE 13G/A Filing | 2026-02-13 | English | ||
| 29064204 | 4 Filing | 2026-02-13 | English | ||
| 29064219 | 4 Filing | 2026-02-11 | English | ||
| 29064206 | 4 Filing | 2026-02-11 | English | ||
| 29064260 | SCHEDULE 13G Filing | 2026-02-10 | English | ||
| 29064212 | 4 Filing | 2026-01-21 | English | ||
| 29064249 | 4 Filing | 2026-01-13 | English | ||
|
2025
1 filing
| |||||
| 11961042 | 8-K | 2025-12-04 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Alembic Ltd
Vertically integrated producer of generic pharmaceuticals a…
|
ALEMBICLTD | IN | Manufacturing |
|
ALEMBIC PHARMACEUTICALS LIMITED
Vertically integrated developer of generic drugs, APIs, and…
|
APLLTD | IN | Manufacturing |
|
ALIVUS LIFE SCIENCES LIMITED
Produces and distributes diverse pharmaceuticals across mul…
|
ALIVUS | IN | Manufacturing |
|
ALK-Abelló
A pharmaceutical company specializing in allergy prevention…
|
ALK | DK | Manufacturing |
|
Alkaloid AD
Manufactures generic pharmaceuticals, cosmetics, and chemic…
|
ALK | MK | Manufacturing |
|
Alkem Laboratories Limited
Develops, manufactures, and markets pharmaceutical and nutr…
|
ALKEM | IN | Manufacturing |
|
Alkermes plc.
Develops and commercializes medicines for central nervous s…
|
ALKS | US | Manufacturing |
|
Allarity Therapeutics, Inc.
A clinical-stage biopharma using diagnostics to develop tar…
|
ALLR | US | Manufacturing |
|
ALLERGY THERAPEUTICS PLC
Immunology company developing aluminum-free vaccines and th…
|
AGY | GB | Manufacturing |
|
Alliance Growers Corp.
Diversified global medical cannabis company focused on CBD …
|
ALGWF | CA | Manufacturing |
PALISADE BIO, INC. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35274/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35274 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35274 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35274 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35274}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for PALISADE BIO, INC. (id: 35274)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.